arrow
返回
P

Paul Grootendorst

university of toronto

31H指数
196论文数
5.4K被引数
收录论文 44
发表时间
err分享
err收藏
The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study
err2024-05-26
err0
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H.
err分享
err收藏
Association between non-medical cannabis legalization and alcohol sales: Quasi-experimental evidence from Canada
err2024-04-01
err2
errOAAI
errMital, Shweta; Bishop, Lisa; Bugden, Shawn; Grootendorst, Paul; V. Nguyen, Hai
err分享
err收藏
Overview of the global vaccine ecosystem
err2023-09-04
err2
errOAAI
errMoradpour, Javad; Chit, Ayman; Besada-Lombana, Sandra; Grootendorst, Paul
err分享
err收藏
Implementation of the appointment-based model in community pharmacies: An analysis of refills and adherence
err2023-09-01
err2
errOAAI
errLin, Qiqi; Mathers, Annalise; Tilli, Tiana; Baker, Jen; Bhaidani, Saleema; Grootendorst, Paul; Cadarette, Suzanne M.; Dolovich, Lisa
err分享
err收藏
Modeling Tiered Pricing Frameworks: A Simulation Approach分层定价框架建模: 一种模拟方法
err2023-03-01
err2
errOAAI
errMoradpour, Javad; Zhang, Wei; Grootendorst, Paul; Anis, Aslam H.; Hollis, Aidan
err分享
err收藏
err分享
err收藏
Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
err2022-05-17
err7
errOAAI
errKonstantelos, N.; Rzepka, A. M.; Burden, A. M.; Cheung, A. M.; Kim, S.; Grootendorst, P.; Cadarette, S. M.
err分享
err收藏
The Impact of Tiered-Pricing Framework on Generic Entry in Canada分层定价框架对加拿大仿制药进入的影响
err2020-11-16
err6
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Lynd, Larry D.; Hollis, Aidan; Grootendorst, Paul; Anis, Aslam H.
err分享
err收藏
The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: A decision-analytic approach
err2019-09-25
err8
PREAI
errErman, Aysegul; Wong, William W. L.; Feld, Jordan J.; Grootendorst, Paul; Krahn, Murray D.
err分享
err收藏
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
err2019-01-10
err75
errOAAI
errJayasundara, Kavisha; Hollis, Aidan; Krahn, Murray; Mamdani, Muhammad; Hoch, Jeffrey S.; Grootendorst, Paul
err分享
err收藏
Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario
err2018-07-24
err2
errOAAI
errGrootendorst, Paul; Shim, Minsup; Falconi, Adam; Robinson, Tyler; Lexchin, Joel
err分享
err收藏
The case for an essential medicines list for Canada
err2016-06-13
err10
errOAAI
errEom, Gina; Grootendorst, Paul; Duffin, Jacalyn
err分享
err收藏
Economic evaluation of vaccines in Canada: A systematic review
err2016-02-18
err8
errOAAI
errChit, Ayman; Lee, Jason K. H.; Shim, Minsup; Van Hai Nguyen; Grootendorst, Paul; Wu, Jianhong; Van Exan, Robert; Langley, Joanne M.
err分享
err收藏
Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments
err2015-11-01
err12
PREAI
errBoutis, Kathy; von Keyserlingk, Camilla; Willan, Andrew; Narayanan, Unni G.; Brison, Robert; Grootendorst, Paul; Plint, Amy C.; Parker, Melissa; Goeree, Ron
err分享
err收藏